-
Eckhardt,M., Langkopf,E., Mark,M., Tadayyon,M., Thomas,L., Nar,H., Pfrengle,W., Guth,B., Lotz,R., Sieger,P., Fuchs,H. and Himmelsbach,F.
8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin -2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes
J Med Chem50, 6450-6453. PubMed Europe PubMed DOI S I
2007
